Compare BAC & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAC | TMO |
|---|---|---|
| Founded | 1784 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.6B | 176.8B |
| IPO Year | N/A | 1996 |
| Metric | BAC | TMO |
|---|---|---|
| Price | $46.68 | $464.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 19 |
| Target Price | $57.58 | ★ $639.83 |
| AVG Volume (30 Days) | ★ 36.9M | 1.9M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 2.38% | 0.36% |
| EPS Growth | N/A | ★ 7.32 |
| EPS | N/A | ★ 17.74 |
| Revenue | N/A | ★ $20,918,000,000.00 |
| Revenue This Year | $12.73 | $6.22 |
| Revenue Next Year | $5.86 | $5.10 |
| P/E Ratio | ★ $14.01 | $26.87 |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $33.07 | $385.46 |
| 52 Week High | $57.55 | $643.99 |
| Indicator | BAC | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 29.59 | 22.36 |
| Support Level | $44.47 | $451.48 |
| Resistance Level | $49.15 | $497.64 |
| Average True Range (ATR) | 1.27 | 12.51 |
| MACD | -0.33 | -1.64 |
| Stochastic Oscillator | 0.42 | 0.43 |
Bank of America is one of the largest financial institutions in the United States, with more than $3.2 trillion in assets. It is organized into four major segments: consumer banking, global wealth and investment management, global banking, and global markets. Bank of America's consumer-facing lines of business include its network of branches and deposit-gathering operations, retail lending products, credit and debit cards, and small-business services. The company's Merrill Lynch operations provide brokerage and wealth-management services, as does its private bank. Wholesale lines of business include investment banking, corporate and commercial real estate lending, and capital markets operations. Bank of America has operations in several countries but is primarily US-focused.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).